Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.
about
Marine natural products as breast cancer resistance protein inhibitorsThe effect of radiation exposure on multidrug resistance: in vitro and in vivo studies using non-small lung cancer cellsSynthesis and biological evaluation of pyrazolo-triazole hybrids as cytotoxic and apoptosis inducing agents.Prediction of anticancer molecules using hybrid model developed on molecules screened against NCI-60 cancer cell lines.Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post-chemotherapy tissuesChitosan nanoparticle-mediated co-delivery of shAtg-5 and gefitinib synergistically promoted the efficacy of chemotherapeutics through the modulation of autophagy.Photochemical activation of drugs for the treatment of therapy-resistant cancers.Drug and gene co-delivery systems for cancer treatment.Synthesis, DNA binding affinity and anticancer activity of novel 4H-benzo[g][1,2,3]triazolo[5,1-c][1,4]oxazocines.Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer.Role of long non-coding RNA in tumor drug resistance.The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study.Safe and Effective Reversal of Cancer Multidrug Resistance Using Sericin-Coated Mesoporous Silica Nanoparticles for Lysosome-Targeting Delivery in Mice.Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines.shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer.Sphingosine-1-Phosphate Receptor-1 Promotes Environment-Mediated and Acquired Chemoresistance.Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate.Crosstalk between long non-coding RNAs and Wnt/β-catenin signalling in cancer.L1210 Cells Overexpressing ABCB1 Drug Transporters Are Resistant to Inhibitors of the N- and O-glycosylation of Proteins.Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles.Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance.Cell-penetrating peptide conjugates to enhance the antitumor effect of paclitaxel on drug-resistant lung cancer.Targeting the tumour stroma to improve cancer therapy.The evolving role of DNA inter-strand crosslinks in chemotherapy.Preparation of psoralen polymer-lipid hybrid nanoparticles and their reversal of multidrug resistance in MCF-7/ADR cells.Nanobiomaterials for pharmaceutical and medical applications.Sericin nanomicelles with enhanced cellular uptake and pH-triggered release of doxorubicin reverse cancer drug resistance.
P2860
Q27027706-170FBBC9-91D9-4E00-BE39-727C3D793382Q35267029-4C61B859-EDBB-46D2-BE5C-FBE5BC202682Q35766298-A485782F-701E-4B6A-9512-C2DCE75E7477Q35918529-CC03F16F-42C4-49BA-BB6C-AEE82EA247DDQ36562337-5821FA50-23BD-420A-BD01-A9DEAE28F0CDQ37747755-4D23A98E-CB8C-4D00-BFD9-8373E96A12F0Q38409528-2B8A7C8B-A8BD-41DD-83E1-DDD3FEB4FF3BQ38556764-0DD3D9C2-D906-4D24-A4CE-4AF1BD78396BQ38742130-812A7581-E114-4230-B19C-2B696BB5BBA9Q38813380-646F8A32-229E-4C8B-8EB0-870A57389D2BQ38886641-58D6BC4D-6A0C-4425-9DC0-8AE2452F0C95Q38999278-9D01E7B7-577D-4331-9A50-170FABC3C34BQ39183648-D21950C7-11F9-4F22-B734-64CD235BCFE5Q39996592-52DDDE57-7489-4744-86E1-36BA90E9EE87Q40926188-5296C5DA-42B6-4183-B73F-6247D3519BBFQ41514180-C9B73874-8D49-4CBE-A224-9014F93CE869Q46444617-8F7A9AAB-29DA-4118-8936-F02174E85BB5Q47128720-C46521D6-AA58-4C71-9FBB-E8E4119BF889Q47697601-7028E99A-15F8-42F6-827B-64CB06F7DE5FQ47838311-51CDEEEB-0E11-4183-AF11-B2531967E882Q49387560-14B46442-0D91-4DE3-A00F-9A75D6232767Q49788112-9E6CD706-6B43-4FCB-AA0E-AC6BECE360FDQ50675888-0CB43574-ED64-4D08-A234-D70B046FDDA4Q52322982-90141309-C201-4F20-AEC1-16D40FE1C5D4Q52691612-4DC67D03-F10F-463E-957B-060F0BFBDDA2Q52716704-F01668BE-F133-46A2-A065-D356958941D9Q53659778-527E11B6-5480-43E2-9943-2477EA26209FQ53685308-607CBE06-8586-412B-B4FD-29AC14514EC7
P2860
Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Cancer multidrug resistance: m ...... using a drug delivery system.
@en
type
label
Cancer multidrug resistance: m ...... using a drug delivery system.
@en
prefLabel
Cancer multidrug resistance: m ...... using a drug delivery system.
@en
P2860
P1476
Cancer multidrug resistance: m ...... n using a drug delivery system
@en
P2093
Golam Kibria
Hideyoshi Harashima
P2860
P2888
P356
10.1007/S12272-013-0276-2
P577
2013-11-23T00:00:00Z
P6179
1016339245